Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension

Hypertension

Volumn 51, Issue 6, 2008, Pages 1637-1642

  Jackson, Edwin K ^a   Mi, Zaichuan ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

CD26; Inbred shr; Kidney; Neuropeptide Y; Rats; Receptors; Renal circulation; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN II; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; PRAZOSIN; SITAGLIPTIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; PEPTIDE FRAGMENT; PYRAZINE DERIVATIVE; TRIAZOLE DERIVATIVE; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEREDITARY HYPERTENSION; KIDNEY CIRCULATION; KIDNEY PERFUSION; KIDNEY VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC NERVE; SYMPATHETIC TONE; ADRENERGIC SYSTEM; ANIMAL; DIABETIC NEPHROPATHY; DRUG POTENTIATION; GENETICS; INNERVATION; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RENOVASCULAR HYPERTENSION;

ANGIOTENSIN II; ANIMALS; DIABETIC NEPHROPATHIES; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DRUG SYNERGISM; HYPERTENSION, RENAL; KIDNEY; MALE; NEUROPEPTIDE Y; PEPTIDE FRAGMENTS; PYRAZINES; RATS; RATS, INBRED SHR; RENAL CIRCULATION; SYMPATHETIC NERVOUS SYSTEM; TRIAZOLES; VASOCONSTRICTOR AGENTS;

EID: 45849115827     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.112532     Document Type: Article

References (19)

1. Dubinion JH, Mi Z, Zhu C, Gao L, Jackson EK. Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction. Hypertension. 2006;47:545-551.
2. Pappas TN, Debas HT, Chang AM, Taylor IL. Peptide YY release by fatty acids is sufficient to inhibit gastric emptying in dogs. Gastroenterology. 1986;91:1386-1389.
3. Armstrong DN, Ballantyne GH, Adrian TE, Bilchik AJ, McMillen MA, Modlin IM. Adaptive increase in peptide YY and enteroglucagon after proctocolectomy and pelvic ileal reservoir construction. Dis Colon Rectum. 1991;34:119-125.
4. Fu-Cheng X, Anini Y, Chariot J, Castex N, Galmiche JP, Roze C. Mechanisms of peptide YY release induced by an intraduodenal meal in rats: neural regulation by proximal gut. Pflugers Arch. Eur J Physiol. 1997;433:571-579.
5. Anini Y, Fu-Cheng X, Cuber JC, Kervran A, Chariot J, Roz C. Comparison of the postprandial release of peptide YY and proglucagon- derived peptides in the rat. Pflugers Arch- Eur J Physiol. 1999;438:299 -306.
6. MacIntosh CG, Andrews JM, Jones KL, Wishart JM, Morris HA, Jansen JB, Morley JE, Horowitz M, Chapman IM. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility. Am J Clin Nutr. 1999;69:999 -1006.
7. Teixeira FV, Pera M, Kelly KA. Enhancing release of peptide YY after near-total proctocolectomy: jejunal pouch vs. ileal pouch-distal rectal anastomosis. J Gastrointest Surg. 2001;5:108 -112.
8. Korner J, Bessler M, Cirilo LJ, Conwell IM, Daud A, Restuccia NL, Wardlaw SL. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insu- lin.[see comment]. J Clin Endocrinol Metab. 2005;90:359-365.
9. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77:75-197.
10. Berglund MM, Hipskind PA, Gehlert DR. Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp Biol Med. 2003;228:217-244.
11. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev. 1998;50:143-150.
12. McIntosh CH, Demuth HU, Pospisilik JA, Pederson R. Dipeptidyl pep- tidase IV inhibitors: how do they work as new antidiabetic agents? Regul Pept. 2005;128:159-165.
13. Jackson EK, Zhang M, Liu W, Mi Z. Inhibition of renal dipeptidyl peptidase IV enhances peptide YY1-36-induced potentiation of angiotensin II-mediated renal vasoconstriction in spontaneously hypertensive rats. J Pharmacol Exp Ther. 2007;323:431-437.
14. Dubinion JH, Mi Z, Jackson EK. Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats. J Pharmacol Exp Ther. 2006;317:1330-1336.
15. Gao L, Zhu C, Jackson EK. alpha 2-Adrenoceptors potentiate angiotensin II- and vasopressin-induced renal vasoconstriction in spontaneously hypertensive rats. J Pharmacol Exp Ther. 2003;305:581-586.
16. + exchanger isoform NHE3 and dipeptidyl peptidase IV in the renal proximal tubule. J Biol Chem. 2001;276:46671-46677.
17. + exchanger NHE3 in rat renal proximal tubule. Am J Physiol Renal Physiol. 2008; 294:F414-422.
18. + exchanger isoform NHE3 in proximal tubule cells. Am J Physiol Cell Physiology. 2004;287: C1238-C1245.
19. Byrd JB, Touzin K, Sile S, Gainer JV, Yu C, Nadeau J, Adam A, Brown NJ. Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema. [see comment]. Hypertension. 2008;51:141-147.